News Column

Venture-Catalyst Springboard Enterprises Appoints Tracy Warren to Its Life Science Council

January 21, 2014

Battelle Ventures General Partner Tracy Warren has been named to the Springboard Enterprises Life Science Council, a network of experts who serve as advisors to the women-led companies in the venture catalyst's accelerator pipeline.

According to a release, Warren, who has worked closely with technology transfer and economic development organizations in medical centers, universities and laboratories around the country, has co-founded a number of life-science companies, including:

-BioNano Genomics (genetic analysis), for which she is board chairman;

-Endovalve (cardiovascular devices), which merged with Micro Interventional Devices, where she serves as board member;

-NellOne Therapeutics (soft-tissue regenerative medicine), for which she is CEO; and

-NuPathe (CNS specialty pharmaceutical), which completed its IPO in 2010 and is to be acquired by Endo Health Solutions.

Having started in venture capital more than a decade ago, Warren also serves as an adviser to PDX Pharmaceuticals, which seeks a treatment for hyperphosphatemia. She is a member of the National Association of Corporate Directors, and is, in the nonprofit area, a Clemson University Research Foundation board member.

"We are fortunate to have Tracy as one of our key industry advisors," said Amy Millman, President Springboard Enterprises.

"She has been an invaluable resource for both our organization and the leaders of such innovative and promising companies as Talk Session, TrueMotion Spine, and Life Cycle Laboratories," Millman continued. "We appreciate her involvement, and naming her as a trusted member of our Life Science Council makes her relationship to Springboard official."

More information:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Health & Beauty Close - Up

Story Tools